GenVec (GNVC) Upside Motion Session; Takeover Battle for Affymetrix (AFFX)


Shares of GenVec, Inc. (Nasdaq:GNVC) soared $0.27 (or +36.99%) to $1.00 on Friday’s trading session. However, there appears to be no relevant information in the street that may explain this movement in the company’s stock

833,800 shares of the clinical-stage gene delivery company were traded during the day, representing a large increase in activity versus its average volume (3m) of 181,095

GenVec has 17.26M Shares Outstanding, Market Capitalization (intraday) of $17.26M and GNVC stock 52-week range is from $0.35 to $3.74 per share



The price of Affymetrix Inc. (Nasdaq:AFFX) stock climbed $1.97 (or +14.05%) to $15.99 and 13,807,189 of its shares exchanged hands on Friday after Origin Technologies Corp. offered to acquire the company for $16.10 per share in cash. A couple months ago, scientific instruments maker Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to buy Affymetrix for $14.00 per share in cash

Affymetrix posted full year 2015 revenue of $359.8 millionand non-GAAP net income of $33.7 million, or $0.42 per diluted share for the period

Affymetrix, which provides life science and molecular diagnostic products, has 80.54M Shares Outstanding, Market Capitalization (intraday) of $1.29B and AFFX stock one-year range is between $8.28 and $16.15 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at